By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Medical gadgets are items designed for human use and serving a medical purpose. In contrast to pharmaceuticals, which have pharmacological, immunological, or metabolic effects, medical devices’ primary intended actions are typically delivered through physical means, such as force.
Implants, items for injection, infusion, transfusion, and dialysis, human medical tools, medical software, catheters, pacemakers, dental products, dressings, visual aids, X-ray equipment, condoms, medical instruments, and laboratory diagnostics are a few examples of medical devices.
Medical devices also include items that contain or are coated with substances or preparations of substances that, when used alone, are regarded as pharmaceuticals or pharmaceutical ingredients (including plasma derivatives) and have the potential to affect the human body in addition to the functions of the device.
The person should first evaluate the intended use (what the medical device performs) and indications for use (the ailment or disease the medical device will diagnose, cure, ameliorate, treat, or prevent) of the device to ascertain whether your product satisfies the FDA definition of a medical device.
The Italy Medical Devices market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2026, registering a CAGR of XX% from 2022 to 2027.
Ferrari and Fiat are in talks with producers of medical equipment to explore how they might help. The two Italian automakers have pledged to increase manufacturing of ventilators, one of the most important medical devices needed nationwide.
According to the article, Ferrari, Fiat Chrysler, and car parts producer Marelli are in talks with the Bologna-based Siare Engineering International Group to develop some parts, source others, and possibly even help assemble the lung ventilators.
These talks between Siare and the automakers aimed to evaluate and comprehend the viability of the two solutions listed below: help Siare increase production capacity at its own facility with assistance from FCA and Ferrari’s technicians.
Following the conclusion of its fruitful pilot project, MedX Health Corp., a world authority in teledermatology, is happy to announce the signing of a commercial distribution deal with Vitamed Biomedical s.r.l. (“Vitamed”).
Vitamed was able to better comprehend the patient journey and gauge market size and expectations thanks to the six-month experiment. According to the pilot’s findings, dermatologists, pharmacists, and other Italian health care providers have a very high degree of approval for the MedX DermSecure Screening Platform.
I-VASC, an Italian manufacturer of medical devices, has announced the closure of a Series A investment for the introduction of its VELEX product. Empty Vein Ablation, a method of treating varicose veins and Chronic Venous Insufficiency (CVI), is possible using VELEX (EVA).
Compared to traditional sclerotherapy, VELEX offers greater safety. Determine market size and projections. According to the pilot’s findings, dermatologists, pharmacists, and other Italian health care providers have a very high degree of approval for the MedX DermSecure Screening Platform.
Hemanext Inc., a pioneer in blood processing, storage, and transfusion technology, announced that it has signed distribution agreements with two of the top medical device distributors in the Nordics and Italy. This will help the company expand its sales into important European markets and strengthen its ties to the region’s most important blood banks and doctors.
Versan & Dafne, a reputable distributor of medical equipment with a long history in Italy, will be an important ally in Hemanext’s marketing plan for the Hemanext ONE system. Both businesses regularly collaborate with major hospitals and other healthcare institutes and have solid market positions in their niches.
As part of its plan for worldwide expansion, the Yorkshire-based regulatory affairs firm Woodley BioReg has established an Italian affiliate. Pharmaceutical, biopharmaceutical, healthcare, and medical device businesses can create and produce products that are efficient and secure for people all around the world with the assistance of Woodley BioReg.
Due to the effects of Brexit, Woodley BioReg has decided to establish a legal entity and new office in Italy. Several EC directives call for a European base for bringing products to the European market, something that Woodley BioReg was unable to provide directly to clients after the UK left the EU and had to rely on European partners.
The first implants in Europe for the recently introduced Optimizer Smart Mini device were just finished in Italy, according to Impulse Dynamics, a commercial-stage medical device business specializing in providing CCM therapy to patients with heart failure.
The new Optimizer Smart Mini system components, which include a rechargeable battery with a 20-year lifespan and new internal technology with improved programming and the potential for remote monitoring in a smaller design to make the implant procedure simpler for patients and doctors, are equally important across international markets.
The Optimizer Smart Mini administers CCM therapy, which uses electric pulses to stimulate the heart between beats to improve the efficiency of cardiac muscular contraction. This improves heart function without raising heart rate or cardiac muscle oxygen consumption.
TytoCare, the first all-in-one modular device and examination platform for AI-powered, on-demand, remote medical tests, announced its launch in Italy, opening the door for widespread adoption of its telehealth solution. TytoCare will be exclusively introduced to the Italian public healthcare market through a relationship with Multimed, a top distribution and commercialization company for medical devices, surgical instruments, robotics, and safety devices.
TytoCare is the only all-encompassing telehealth service that enables doctors to remotely connect with patients for physical examinations of clinic-quality. Users of the portable examination tool can do thorough physical examinations of the heart, skin, ears, throat, abdomen, lungs, and body temperature, all of which are essential for monitoring COVID-19.
For primary and chronic care settings, the solution perfectly simulates an in-person visit from any location, at any time, and by offering remote care for both isolated patients at home and quarantined patients in hospitals, it contributes to stopping the spread of the virus. This enables physicians to gather the crucial clinical information they need to remotely monitor and treat patients.
